FDA Approves Pfizer Booster For Children Ages 12-15
ATLANTA, GA – OCTOBER 13: Exterior of the Center for Disease Control (CDC) headquarters is seen on October 13, 2014 in Atlanta, Georgia. Frieden urged hospitals to watch for patients with Ebola symptoms who have traveled from the tree Ebola stricken African countries. (Photo by Jessica McGowan/Getty Images)
The FDA has approved booster shots of the Pfizer-BioNTech COVID-19 vaccine for children ages 12-15.
The agency also shortened the recommended timeframe for getting a booster to five months after the second shot, down from six months.
Children ages 5-11 who are immunocompromised are also approved for a booster shot.
The CDC will review the FDA’s decision before it takes effect.
